Article
The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol.
British journal of clinical pharmacology - 1 Jan 2004
Lee Daniel K C, Currie Graeme P, Hall Ian P, Lima John J, Lipworth Brian J
Abstract excerpt
AIMS: The relationship between beta2-adrenoceptor polymorphisms and bronchoprotective response with long-acting beta2-adrenoceptor agonists is unknown. METHODS: We retrospectively analysed data from six placebo-controlled randomized studies in corticosteroid treated asthmatics where formoterol or salmeterol were administered over a 1-2-week period, with prior 1-2 week washout, assessing the primary end point of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
